Safety & Tolerability of the IRay System in Subjects With Exudative Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)

NCT01217762 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

Age-Related Macular Degeneration
Wet Age-Related Macular Degeneration
Macular Degeneration
Eye Diseases
Retinal Diseases

Interventions

DEVICE: IRay

Sponsor

Oraya Therapeutics, Inc.